AbbVie brings 7 presentations to BPI 2026 in Boston. Its program leans toward real-time process monitoring and control, alongside drug product and validation work. Topics include scalable Raman chemometric models, a robust lyophilization process for a bispecific antibody, and which genetic characterization actually matters in cell line development.
| Organization | BPI 2026 Attendance |
|---|---|
AbbVie North Chicago, Illinois | 1 Principal AI Engineer · 1 Senior Scientist II · 1 Principal Research Scientist, · 1 Principal Scientist · 1 other speaker |
Global pharmaceutical company developing and manufacturing biologics, including antibodies and antibody-drug conjugates. | Chair Wed Sep 23 8:55am–9:00am Talk Wed Sep 23 11:15am–11:45am Chair Wed Sep 23 1:55pm–2:00pm Panel Wed Sep 23 2:30pm–3:00pm Talk Thu Sep 24 4:30pm–5:00pm Talk Fri Sep 25 11:45am–12:15pm Talk Fri Sep 25 2:00pm–2:30pm |
Instantly find 20 buyers from AbbVie
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction